- Home
- QSI vs PRQR Comparison
QSI vs PRQR Comparison
Compare QSI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QSI | PRQR |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | Netherlands |
| Employees | 145 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.8M | 167.5M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | QSI | PRQR |
|---|---|---|
| Price | $0.90 | $1.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $1.00 | ★ $6.80 |
| AVG Volume (30 Days) | ★ 5.0M | 774.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $618.07 | $13.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.69 | $1.33 |
| 52 Week High | $3.10 | $3.10 |
Technical Indicators
Market Signals| Indicator | QSI | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 49.48 | 38.83 |
| Support Level | $0.69 | $1.34 |
| Resistance Level | $1.10 | $1.58 |
| Average True Range (ATR) | 0.08 | 0.16 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 42.69 | 0.71 |
Price Performance
Historical ComparisonAbout QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.